Literature DB >> 29214284

Characteristics of Medical Liability Claims Against Dermatologists From 1991 Through 2015.

Heather Kornmehl1, Sanminder Singh2, Brandon L Adler3, Alexander E Wolf4, Dean A Bochner5, April W Armstrong3.   

Abstract

Importance: Recognizing malpractice trends in the field of dermatology is important for establishing safeguards for patient care and minimizing liability. However, there is a lack of published data on malpractice claims against dermatologists. Objective: To determine characteristics of medical professional liability claims in the field of dermatology and to compare these claims with those against all physicians. Design, Setting, and Participants: We examined malpractice liability data collected on dermatologists and other physicians insured by companies that report data to the Physician Insurers Association of America Data Sharing Project (PIAA-DSP), a nationally representative liability claims registry. Data analyzed spanned the years 1991 through 2015. Main Outcomes and Measures: Demographic characteristics of dermatologists subject to claims, characteristics of closed claims, medical errors associated with closed claims, and patient outcomes leading to closed claims.
Results: Data on a total of 90 743 closed claims were analyzed, 1084 (1.2%) against dermatologists and 89 659 (98.8%) against nondermatologists. More lawsuits were brought against male (n = 753, 69.5%) than female dermatologists (n = 270, 24.9%); 5.6% of claims (n = 61) did not identify the physician's sex. Full-time practitioners (n = 1035, 95.5%) and those in solo practice (n = 600, 55.4%) were more likely to be sued than those in group practices (n = 429, 39.6%) and institutions (n = 31, 2.9%). Most claims against dermatologists were abandoned, withdrawn, or dismissed (n = 735, 67.8%). Between 2006 and 2015, trial verdicts favoring defendants exceeded trial verdicts favoring plaintiffs by a factor of 7. Errors that occurred during a procedure spawned the most claims (n = 305), of which 102 were paid. Misdiagnoses comprised the second-highest number of claims (n = 192), of which 62 were paid. The average recovery per claim was $238 145. The most common procedure leading to claims was skin operations (420 claims, of which 130 were paid). The most common adverse patient outcome associated with claims was dyschromia, resulting in 171 claims, of which 40 were paid. Conclusions and Relevance: Male dermatologists were sued more often than female dermatologists. Overall, alleged errors in procedures and misdiagnosis gave rise to the most lawsuits. Dyschromia was the most common adverse outcome alleged in lawsuits.

Entities:  

Mesh:

Year:  2018        PMID: 29214284      PMCID: PMC5839273          DOI: 10.1001/jamadermatol.2017.3713

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN: 2168-6068            Impact factor:   10.282


  25 in total

1.  Physician gender effects in medical communication: a meta-analytic review.

Authors:  Debra L Roter; Judith A Hall; Yutaka Aoki
Journal:  JAMA       Date:  2002-08-14       Impact factor: 56.272

2.  Diagnostic error in internal medicine.

Authors:  Mark L Graber; Nancy Franklin; Ruthanna Gordon
Journal:  Arch Intern Med       Date:  2005-07-11

3.  Noncosmetic skin-related procedures performed in the United States: an analysis of national ambulatory medical care survey data from 1995 to 2010.

Authors:  Christine S Ahn; Scott A Davis; Tushar S Dabade; Phillip M Williford; Steven R Feldman
Journal:  Dermatol Surg       Date:  2013-11-14       Impact factor: 3.398

4.  Physician-patient communication. The relationship with malpractice claims among primary care physicians and surgeons.

Authors:  W Levinson; D L Roter; J P Mullooly; V T Dull; R M Frankel
Journal:  JAMA       Date:  1997-02-19       Impact factor: 56.272

5.  Malpractice risk according to physician specialty.

Authors:  Anupam B Jena; Seth Seabury; Darius Lakdawalla; Amitabh Chandra
Journal:  N Engl J Med       Date:  2011-08-18       Impact factor: 91.245

Review 6.  Postinflammatory hyperpigmentation: etiologic and therapeutic considerations.

Authors:  Valerie D Callender; Sharleen St Surin-Lord; Erica C Davis; Marissa Maclin
Journal:  Am J Clin Dermatol       Date:  2011-04-01       Impact factor: 7.403

Review 7.  Drug-induced skin pigmentation. Epidemiology, diagnosis and treatment.

Authors:  O Dereure
Journal:  Am J Clin Dermatol       Date:  2001       Impact factor: 7.403

8.  Liability claims and costs before and after implementation of a medical error disclosure program.

Authors:  Allen Kachalia; Samuel R Kaufman; Richard Boothman; Susan Anderson; Kathleen Welch; Sanjay Saint; Mary A M Rogers
Journal:  Ann Intern Med       Date:  2010-08-17       Impact factor: 25.391

9.  Fifteen years after To Err is Human: a success story to learn from.

Authors:  Peter J Pronovost; James I Cleeman; Donald Wright; Arjun Srinivasan
Journal:  BMJ Qual Saf       Date:  2015-12-15       Impact factor: 7.035

Review 10.  Sex differences in medico-legal action against doctors: a systematic review and meta-analysis.

Authors:  Emily Unwin; Katherine Woolf; Clare Wadlow; Henry W W Potts; Jane Dacre
Journal:  BMC Med       Date:  2015-08-13       Impact factor: 8.775

View more
  1 in total

1.  Characteristics of State and Federal Malpractice Litigation of Medical Liability Claims for Keratinocyte Carcinoma, 1968 to 2018.

Authors:  Raghav Tripathi; Harib H Ezaldein; Krithika Rajkumar; Jeremy S Bordeaux; Jeffrey F Scott
Journal:  JAMA Dermatol       Date:  2019-07-01       Impact factor: 10.282

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.